Skip to main content
Skip to content
Case File
efta-01519530DOJ Data Set 10Other

EFTA01519530

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01519530
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL - OAP IHD ACCT For the Period 3/1/14 to Equity Summary Asset Categories Beginning Ending Change Cogent Markel Value Market Value In Value Allocation rAri FTht it, 137,528.10 0.00 (137,528.10) Equity Detail Price Quantity Value Adjusted Tax Cost Unrealized Gainitoss Est. Annual Inc. Yield Original Cost Accrued Div. EAFE Equity GLAXOSMITHKLINE PLC 53.43 0.00 4.62% SPONS ADR 684.77 37733W-10.5 GSK KIRIN HOLDINGS COMPANY LTD 13.85 0.00 2.00% SPONS ADR 476.23 497350-30-6 KNBW RECKITT BENCKISER GROUP PLC 16 48 0.00 2.57% SPONSORED ADR 776.95 756255-20-4 RBGL Total EAFE Equity $0.00 $0.00 50.00 50.00 0.00% 31.937.95 J.P. Morgan Account Page 3 et . Consolidated Statement Page 31 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046820 SDNY_GM_00316018 EFTA01519530

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.